Biphasic squamoid alveolar renal carcinoma with positive CD57 expression: A clinicopathologic study of three cases

Pathol Int. 2019 Sep;69(9):519-525. doi: 10.1111/pin.12844. Epub 2019 Aug 1.

Abstract

Biphasic squamoid alveolar renal cell carcinoma (BSARCC) is a rare and recently characterized form of papillary renal cell carcinoma (PRCC). Herein, we describe three cases of BSARCC that were CD57+. Among a total of 90 cases of PRCC, three cases were found to be consistent with a diagnosis of BSARCC. In addition to reviewing these cases, we reviewed the relevant literature pertaining to this form of cancer and assessed the immunohistochemical staining for CD57 on the available tumor samples. The three BSARCC cases in the present study were composed of two primary populations of cells. Tumors stained positive for CK, PAX8, CK7, CK19, AMACR, EMA, and vimentin. Larger cells expressed detectable levels of cyclin D1, and expression of CD57 was limited to the larger cells. All three patients were alive and free of disease during the most recent follow-up. Our results suggest that the CD57 positivity of at least a subset of cases should necessitate their differentiation from cases of metanephric adenoma.

Keywords: BSARCC; CD57; cyclin D1; metanephric adenoma; papillary RCC.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Biomarkers, Tumor / analysis*
  • Carcinoma, Renal Cell / diagnostic imaging
  • Carcinoma, Renal Cell / metabolism
  • Carcinoma, Renal Cell / pathology*
  • Follow-Up Studies
  • Humans
  • Immunohistochemistry
  • Kidney / diagnostic imaging
  • Kidney / pathology
  • Kidney Neoplasms / diagnostic imaging
  • Kidney Neoplasms / metabolism
  • Kidney Neoplasms / pathology*
  • Male
  • Middle Aged

Substances

  • Biomarkers, Tumor